SFMG, LLC

SEC CIK: 0001512026
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by SFMG, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overview All 13F holders of VRTX Full Q2 2026 holdings

Shares (Q2 2026): 3,659
Value: $1.82M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of VRTX by SFMG, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	3,659	$1.82M	0.1%	−162−4.2%	Reduced	Holders
Q1 2026	3,821	$1.71M	0.1%	−341−8.2%	Reduced	Holders
Q4 2025	4,162	$1.89M	0.1%	−393−8.6%	Reduced	Holders
Q3 2025	4,555	$1.78M	0.1%	−78−1.7%	Reduced	Holders
Q2 2025	4,633	$2.06M	0.2%	−2,905−38.5%	Reduced	Holders
Q1 2025	7,538	$3.65M	0.3%	−111−1.5%	Reduced	Holders
Q4 2024	7,649	$3.08M	0.2%	−96−1.2%	Reduced	Holders
Q3 2024	7,745	$3.60M	0.3%	−100−1.3%	Reduced	Holders
Q2 2024	7,845	$3.68M	0.3%	+60+0.8%	Added	Holders
Q1 2024	7,785	$3.25M	0.3%	+64+0.8%	Added	Holders
Q4 2023	7,721	$3.14M	0.3%	+982+14.6%	Added	Holders
Q3 2023	6,739	$2.34M	0.2%	−1,970−22.6%	Reduced	Holders
Q2 2023	8,709	$3.06M	0.3%	−21−0.2%	Reduced	Holders
Q1 2023	8,730	$2.75M	0.3%	+15+0.2%	Added	Holders
Q4 2022	8,715	$2.52M	0.3%	00.0%	Unchanged	Holders
Q3 2022	8,715	$2.53M	0.3%	00.0%	Unchanged	Holders
Q2 2022	8,715	$2.46M	0.3%	−193−2.2%	Reduced	Holders
Q1 2022	8,908	$2.33M	0.2%	−72−0.8%	Reduced	Holders
Q4 2021	8,980	$1.97M	0.2%	+1,070+13.5%	Added	Holders
Q3 2021	7,910	$1.44M	0.2%	−110−1.4%	Reduced	Holders
Q2 2021	8,020	$1.62M	0.2%	+1,950+32.1%	Added	Holders
Q1 2021	6,070	$1.30M	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.